This Viewpoint discusses mechanisms by which the human microbiome might influence risk of obesity, type 2 diabetes, and atherosclerosis, and ways in which the microbiome might be manipulated to reduce those risks.
No takes yet. Share an insight, caveat, or question.
Anthony L. Komaroff (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: